Heba Jalloun | Medicine and Dentistry | Best Researcher Award

Dr. Heba Jalloun | Medicine and Dentistry | Best Researcher Award

King Fahd Armed Forces Hospital from Saudi Arabia

Dr. Heba Essam Jalloun is a highly accomplished consultant in colorectal, minimally invasive, and robotic surgery, currently based at King Fahd Armed Forces Hospital (KFAFH) in Jeddah, Saudi Arabia. With over two decades of extensive clinical, academic, and research experience, Dr. Jalloun has demonstrated a steadfast commitment to the advancement of surgical practice, training, and innovation in her field. She earned her Bachelor’s degree in Medicine and Surgery from King Abdul-Aziz University in 2000, followed by the Saudi Specialty Certificate in General Surgery in 2008. Her international training includes two prestigious fellowships in South Korea focusing on minimally invasive, laparoscopic, robotic, oncology, and pelvic floor surgeries. Beyond her clinical responsibilities, she actively participates in training future surgeons as the Director of the General Surgery Saudi Board Residency Program at KFAFH. Dr. Jalloun is widely recognized for her contributions as a speaker at national and international conferences, as well as her active participation in surgical societies across Saudi Arabia, Europe, and Asia. Her work during the COVID-19 pandemic as a frontliner and her extensive involvement in global research collaborations further emphasize her dedication to both patient care and the academic community.

Professional Profile

Education

Dr. Heba Jalloun’s educational foundation is rooted in excellence and international exposure. She began her medical education at King Abdul-Aziz University, where she earned her Bachelor’s degree in Medicine and General Surgery (MBChB) between 1994 and 2000. After passing the Saudi License Exam in 2000, she pursued her residency in General Surgery through the Saudi Board program, completing her Saudi Specialty Certificate in General Surgery (SSC-SURG) in 2008. Her postgraduate training was distinguished by a strong focus on advanced surgical techniques, particularly in minimally invasive procedures. She furthered her expertise through two consecutive fellowships in South Korea: one in Minimal Invasive Surgery, Laparoscopic & Robotic Surgery for Colorectal Diseases (2015–2016), and the second in Oncology, Proctology, and Pelvic Floor Surgery (2017). These fellowships were undertaken at the Catholic University of Korea, Seoul St. Mary’s Hospital, providing her with global perspectives and high-level surgical training. Dr. Jalloun also acquired numerous certifications including ATLS instructor, Basic Surgical Skills instructor, Advanced Cardiac Life Support, and the Train of Trainer (TOT) program. Her dedication to continuous professional development is further evident through her involvement in structured surgical courses and certifications that support both clinical excellence and teaching proficiency.

Professional Experience

Dr. Heba Jalloun’s professional career spans over two decades of dedicated service, with a significant focus on general, colorectal, and robotic surgery. She began her journey in clinical practice as a resident in family medicine from 2001 to 2003, then transitioned into general surgery residency at Northwest Armed Forces Hospital and King Abdulaziz & Oncology Center from 2003 to 2008. After receiving her board certification, she was appointed as a Registrar and later an Assistant Consultant in General Surgery at KFAFH. Her expertise and leadership were recognized as she advanced to the roles of General Surgery Consultant in 2014 and Colorectal, Minimally Invasive, and Robotic Surgery Consultant in 2018. In 2022, she was appointed Director of the Saudi Board General Surgery Residency Program at KFAFH. Alongside clinical duties, Dr. Jalloun has led and organized numerous simulation-based training courses, contributed significantly to resident education, and participated in advanced surgical workshops both nationally and internationally. Her role during the COVID-19 pandemic as a frontliner and key investigator in global surgical research further highlights her dynamic and compassionate leadership. She is also an active member of surgical societies in Saudi Arabia and abroad, bridging international best practices with local healthcare advancements.

Research Interests

Dr. Heba Jalloun’s research interests are aligned closely with her clinical expertise in colorectal surgery, minimally invasive techniques, and oncology. She is deeply engaged in advancing surgical methodologies through evidence-based studies and is particularly focused on Enhanced Recovery After Surgery (ERAS) protocols, outcomes of laparoscopic procedures, and the management of colorectal diseases. Her international collaborations reflect her commitment to global health challenges, especially in the context of the COVID-19 pandemic, where she co-authored several high-impact publications addressing surgical delays, postoperative complications, and vaccine safety related to surgical outcomes. Additionally, she is interested in surgical education, clinical audits, and quality improvement projects—particularly those improving patient discharge efficiency and postoperative recovery. Dr. Jalloun has also explored surgical techniques in emergency abdominal procedures and rare case reports, including drug addiction among high school students. Her current and ongoing research includes hospital-based projects, international multicenter cohort studies, and case series publications. Through this multifaceted research approach, Dr. Jalloun aims to bridge gaps between clinical practice and academic inquiry, ultimately contributing to improved patient safety, surgical precision, and innovation in healthcare systems across the region and globally.

Research Skills

Dr. Heba Jalloun possesses a strong portfolio of research skills encompassing clinical study design, data collection, analysis, publication, and academic presentations. She has served as a principal investigator for several international multicenter studies focused on elective cancer surgery, acute cholecystitis, and surgical outcomes during the COVID-19 pandemic. Her contributions demonstrate proficiency in conducting prospective cohort studies, managing collaborative global datasets, and interpreting clinical implications across diverse healthcare settings. Additionally, Dr. Jalloun is skilled in writing and reviewing scientific manuscripts, poster presentations, and case reports. Her research on ERAS protocols, laparoscopic surgery outcomes, and oncologic safety has been published in respected international journals. She actively contributes to hospital-based quality improvement projects and is proficient in coordinating multidisciplinary research teams. Dr. Jalloun’s training experience also equips her with excellent skills in presenting at international symposiums, conducting workshops, and teaching evidence-based surgical practices. Her ability to integrate research into clinical practice makes her an asset to both academic and medical institutions. Furthermore, her dedication to mentorship and supervision of trainees in research-related tasks reinforces her role as a leader in academic medicine and clinical education.

Awards and Honors

Dr. Heba Jalloun has received multiple awards and honors in recognition of her clinical excellence, teaching capabilities, and service to the healthcare community. She was honored with the Best Instructor and Teacher award at King Fahd Armed Forces Hospital (KFAFH) for the academic year 2019–2020, reflecting her impactful contributions to surgical education. Earlier in her career, she was recognized as the Best Senior Registrar in 2010–2011, showcasing her exceptional performance during residency. Her role as an instructor in ATLS and Basic Surgical Skills courses since 2005 further highlights her longstanding commitment to surgical training. Dr. Jalloun received certificates of appreciation for her contributions to patient safety and experience in both 2021 and 2023, underlining her dedication to improving healthcare quality. During the COVID-19 pandemic, she was acknowledged for her invaluable service as a frontliner and key investigator in international research collaborations. Additionally, she has been commended for her participation as a speaker in numerous national and international symposiums. These accolades collectively reflect her multifaceted contributions as a surgeon, educator, researcher, and leader committed to advancing the field of surgery and patient care at both national and global levels.

Conclusion

In conclusion, Dr. Heba Essam Jalloun exemplifies the qualities of a distinguished surgeon, educator, and researcher, making her a strong candidate for the Best Researcher Award. Her career demonstrates an exceptional balance between clinical practice, academic leadership, and impactful research contributions. Through her international training in advanced surgical techniques and ongoing participation in global collaborative studies, she has significantly enriched both patient outcomes and medical knowledge. Her work during the COVID-19 pandemic, alongside her numerous publications and hospital projects, highlights her commitment to addressing real-world challenges with scientific rigor. Dr. Jalloun’s leadership in surgical education, evident from her role as Director of the Saudi Board Residency Program, further establishes her as a mentor and role model for future generations of surgeons. With multiple awards recognizing her teaching, service, and research, she has shown unwavering dedication to excellence in healthcare. While her work is already commendable, expanding her independent research leadership and engaging in broader interdisciplinary projects could further enhance her impact. Overall, Dr. Jalloun’s credentials and achievements reflect not only her expertise but also her vision for continuous innovation and improvement in surgery and medical education. She is a highly deserving candidate for this prestigious recognition.

Publications Top Notes

  • Title: Influence of the Enhanced Recovery After Surgery Protocol on Postoperative Inflammation and Short-Term Postoperative Surgical Outcomes After Colorectal Cancer Surgery

  • Authors: Jalloun Heba Essam (H.E.), Lee In Kyu (I.K.), Kim Min-ki (M.), Lee Yoon-suk (Y.), Jeon Hae-myung (H.)

  • Year: 2020

  • Citations: 19

Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Dr. Mawande Mayibenye | Medicine and Dentistry | Best Researcher Award

Gynaecologist at Walter Sisulu University, South Africa

Dr. M. Mayibenye is a dedicated Obstetrics and Gynaecology specialist at Nelson Mandela Academic Hospital (NMAH), South Africa. With a strong academic foundation, a proven record of research in maternal health, and a commitment to advancing clinical practice, Dr. Mayibenye stands out as an emerging leader in the field. She has presented her work at prominent national conferences, including SASUOG and SAATOG, contributing to critical discussions on obstetric care. Her research focuses on improving surgical outcomes for repeat cesarean sections, with practical applications that enhance patient care. Dr. Mayibenye is also actively involved in professional organizations like HPCSA, SAMA, and ISUOG, further enriching her academic and clinical journey.

Professional Profile

Education

Dr. Mayibenye’s academic achievements include completing her MBChB in 2015 and MMED in 2022, both from Walter Sisulu University (WSU). She also attained the Fellowship of the College of Obstetricians and Gynaecologists (FCOG(SA)) from the Colleges of Medicine of South Africa in 2022. These qualifications reflect her rigorous training and expertise in the field. Her journey began with matriculation from Dimanda Secondary School in 2009. Dr. Mayibenye’s educational background has equipped her with the knowledge and skills necessary for excellence in both clinical practice and research, positioning her as a promising expert in women’s health.

Professional Experience

Dr. Mayibenye has gained substantial clinical experience since joining NMAH as a community service doctor in 2018. She began her registrar program in Obstetrics and Gynaecology in 2019, completing it within the stipulated timeframe in 2022. Since then, she has been working as a specialist at NMAH, contributing to the department through her clinical expertise and dedication to maternal care. Her professional experience also includes completing her internship at NMAH in 2017 and community service in 2018. Through her roles, Dr. Mayibenye has demonstrated exceptional commitment to improving women’s health outcomes, combining her clinical skills with research insights to deliver impactful results.

Research Interests

Dr. Mayibenye’s research interests focus on improving outcomes in obstetric surgeries, particularly in predicting complications during repeat cesarean sections. Her MMED research explored pre-operative prediction of severe intraperitoneal adhesions using clinical signs and sliding sign, addressing a critical need for safer surgical planning. This area of interest reflects her dedication to maternal health and patient safety, with a specific focus on evidence-based approaches to minimize surgical risks. Dr. Mayibenye is also passionate about advancing diagnostic methods and contributing to the broader understanding of obstetric care challenges in resource-constrained settings.

Research Skills

Dr. Mayibenye possesses advanced research skills honed through her academic and clinical work. She is proficient in designing and conducting clinical studies, data analysis, and translating findings into practical applications. Her expertise includes presenting complex research findings at national conferences such as SASUOG and SAATOG, where she has effectively communicated her work to peers and experts. Dr. Mayibenye is skilled in systematic literature reviews, clinical data interpretation, and the use of diagnostic tools for surgical prediction. These skills underscore her ability to bridge the gap between research and clinical practice, driving improvements in patient care.

Awards and Honors

Dr. Mayibenye’s academic and professional journey reflects numerous milestones of achievement. Notable accomplishments include her completion of the MMED program and earning the prestigious FCOG(SA) designation from CMSA in 2022. Her selection to present research at leading conferences such as SASUOG, SAATOG, and the 41st Conference on Priorities in Perinatal Care in Southern Africa highlights her recognition as a contributor to critical discussions in obstetrics. Dr. Mayibenye’s continuous involvement in professional organizations like SAMA and ISUOG further emphasizes her dedication to advancing her field through collaboration and knowledge dissemination.

Conclusion

Dr. M. Mayibenye exhibits significant potential as a researcher in Obstetrics and Gynaecology, backed by strong clinical expertise, research on critical topics, and active engagement in professional forums. To excel in competitions for the Best Researcher Award, additional publications in high-impact journals, diversification of research focus, and increased international exposure could strengthen their candidacy. Overall, Dr. Mayibenye is a suitable candidate with promising contributions and growth potential in the field.

 

 

Minji Jung | Health Professions | Best Researcher Award

Dr. Minji Jung | Health Professions | Best Researcher Award

Postdoctoral Scholar at Stanford University Medical Center, United States

Minji Jung is a prominent researcher with expertise in cancer epidemiology, pharmacoepidemiology, and risk factors for chronic diseases such as kidney cancer and cardiovascular conditions. She currently serves as a Postdoctoral Scholar at the Urologic Cancer Epidemiology Lab at Stanford University School of Medicine. Minji has an extensive academic background, earning a PhD in Clinical Pharmacoepidemiology and holding a PharmD degree from Ajou University, South Korea. Her research has spanned multiple high-impact areas, including kidney cancer, cardiovascular diseases, and dementia, with a focus on real-world data analysis. Minji has secured significant research funding, led interdisciplinary projects, and earned numerous awards, underscoring her substantial contributions to health sciences. Her work integrates diverse data sets, cutting-edge statistical methods, and collaborative partnerships, making her a leading figure in her field.

Professional Profile

Education:

Minji Jung holds a PharmD from Ajou University in South Korea, completed in 2016, where she also earned her PhD in Clinical Pharmacoepidemiology in 2021. During her doctoral studies, Minji focused on evaluating the pleiotropic effects of statin therapy, specifically investigating its potential role in preventing hemorrhagic stroke and dementia using Korean nationwide health insurance data. She has further honed her expertise as a Research Fellow at the University of California, San Francisco, in 2021-2022, specializing in pharmacoepidemiology related to cardiovascular disease. Minji’s education has been marked by a strong foundation in clinical pharmacy, epidemiology, and data analytics, laying the groundwork for her current focus on urologic cancer and cardio-oncology research.

Professional Experience:

Minji Jung’s professional journey includes roles in academia and research, where she has made significant strides in clinical pharmacy and epidemiology. She is currently a Postdoctoral Scholar at Stanford University’s Urologic Cancer Epidemiology Lab, where she focuses on cancer epidemiology, pharmacoepidemiology, and kidney cancer research. Previously, she served as a Research Fellow at the University of California, San Francisco, contributing to studies on cardiovascular disease and medication adherence. Minji’s early research experience includes working at Ajou University, South Korea, where she contributed to pharmacoepidemiological projects examining the effects of statin use and its association with stroke and dementia. Her expertise spans across both clinical and epidemiological settings, enabling her to integrate real-world data into her research and offering valuable insights into chronic disease prevention and management.

Research Interests:

Minji Jung’s research interests are centered on cancer epidemiology, pharmacoepidemiology, and the intersection of chronic diseases such as kidney cancer, cardiovascular conditions, and dementia. Her work focuses on understanding the epidemiology and risk factors associated with kidney cancer, analyzing large health data sets to explore connections between metabolic syndrome and cancer incidence. Additionally, Minji is deeply invested in survivorship and psycho-oncology, exploring the mental and physical health outcomes of patients diagnosed with cancer. Her research also delves into cardio-oncology, investigating the cardiovascular risks of cancer patients, especially those undergoing treatment. By using advanced statistical methods and diverse global data sets, Minji aims to improve the prevention, diagnosis, and treatment of chronic diseases, with a focus on kidney cancer and its broader implications for public health.

Research Skills:

Minji Jung possesses advanced research skills, particularly in epidemiological methods, pharmacoepidemiology, and statistical analysis. She is adept at handling large, diverse data sets, such as SEER, UK Biobank, and MarketScan® data, and has expertise in applying a variety of statistical techniques, including logistic regression, survival analysis, propensity score matching, and Cox regression models. Minji is skilled in utilizing real-world data to study the epidemiology of chronic diseases and their interactions with medications. Her proficiency in data analysis is complemented by her ability to integrate findings from multiple disciplines, allowing her to draw meaningful conclusions that influence clinical and public health policies. Minji is also experienced in project management, having led her own research initiatives, and is well-versed in the application of innovative research methods to investigate complex health issues.

Awards and Honors:

Minji Jung has received numerous awards in recognition of her exceptional research contributions. Notably, she was honored with the Poster Award from the Western Section of the American Urological Association in 2024 and was selected as a Notable Scientist by the Korean Biological Research Information Center in 2023. She also won the Oral Presentation Award at the 24th Annual Spring Research Seminar at the University of California, San Francisco, in 2022. Minji’s achievements are further highlighted by an Oral Presentation Award from the Pharmaceutical Society of Korea in 2019, as well as a Certificate of Commendation from the Suwon Pharmaceutical Association in 2018. These accolades reflect the high regard in which she is held by the scientific community, emphasizing her impactful research in the fields of epidemiology and pharmacoepidemiology.

Conclusion

Minji Jung has demonstrated exceptional research capabilities in areas that have profound implications for public health, particularly in cancer epidemiology and pharmacoepidemiology. Her leadership in securing research grants and contributing to significant health-related findings sets her apart as a candidate for the Best Researcher Award. While there are areas that could be further strengthened, particularly in terms of broadening her influence in the public sphere and maximizing publication impact, her accomplishments thus far make her a highly deserving nominee for the award.

Publication Top Notes

  • Effects of statin therapy on the risk of intracerebral hemorrhage in Korean patients with hyperlipidemia
    Authors: M Jung, S Lee
    Year: 2019
    Citations: 22
  • Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease
    Authors: MY Kim, M Jung, Y Noh, S Shin, CH Hong, S Lee, YS Jung
    Year: 2020
    Citations: 18
  • Efficacy of aspirin in the primary prevention of cardiovascular diseases and cancer in the elderly: a population-based cohort study in Korea
    Authors: M Jung, S Lee
    Year: 2020
    Citations: 10
  • Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide
    Authors: G Jin, HV Ngo, J Wang, JH Cui, QR Cao, C Park, M Jung, BJ Lee
    Year: 2022
    Citations: 8
  • Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea
    Authors: M Jung, E Choo, S Lee
    Year: 2020
    Citations: 7
  • Comparing the sensitivities of measures of adherence to antihypertensive drugs using Korean National Health Insurance Claims Data
    Authors: E Choo, M Jung, J Shin, S Lee
    Year: 2021
    Citations: 5
  • Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation
    Authors: YM Sohn, RE Ko, HJ Park, E Choo, M Jung, S Lee, K Jeon
    Year: 2023
    Citations: 1
  • A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean National Health Insurance Claims Data
    Authors: M Jung, E Choo, S Lee
    Year: 2023
    Citations: 1
  • Effects of Postprandial Factors and Second Meal Intake Time on Bioequivalence Investigation of Tadalafil-Loaded Orodispersible Films in Human Volunteers
    Authors: SJ Park, MC Gil, BS Lee, M Jung, BJ Lee
    Year: 2024
    Citations: Not listed yet
  • Air pollution mixture associated with oxidative stress exacerbation and symptoms deterioration in allergic rhinitis patients: Evidence from a panel study
    Authors: J Li, H Wu, W Xing, X Li, Z Han, R Ji, Z Deng, M Jung, S Sun, BI Chung, …
    Year: 2024